As a result of its high production volumes, use in a wide range of products, and its possible adverse impacts on human health, investigations of human BPA exposure based on population level are of high importance.
The present study is one of the first comprehensive investigations of BPA exposure in Austria based on large data and sampling material from the Austrian Study of Nutritional Status 2010/2012 (ASNS). Total BPA concentrations were analysed in spontaneous urine samples of an Austrian study population consisting of children and adolescents aged 6-15 years, adults aged 18-64 years and senior citizens aged ≥65 years. Based on urinary concentrations, daily BPA intakes (DIs) were estimated and compared to the Tolerable Daily Intake (TDI) set out by the European Food Safety Authority (EFSA) in 2015 and the Reference Dose (RfD) set out by the Environmental Protection Agency of the United States (U.S. EPA). Additionally, results from the present study were compared with findings from previous investigations in order to identify possible differences and trends.
Materials and methods

Study design and study population
The Austrian Study on Nutritional Status (ASNS) was conducted between 2010 and 2012 comprising a total of 1002 male and female participants aged 6-15 and 18-81 years through a quota sampling of a cross-sectional study. Participants were recruited from almost all Austrian federal states, with data on nutrition, health status, education and employment being collected via questionnaires. Additionally, spontaneous urine samples were collected before midday. The detailed procedure of recruitment and sampling was described elsewhere [12] .
For the investigation of BPA exposure among the study population, surveyed data and urine samples of more than half of the participants recruited during the ASNS were provided to the Environment Agency Austria (EAA) depending on the availability of sufficient sample material. The study population included 594 participants: 253 children and adolescents aged 6-15 years (138 males and 115 females), 275 adults aged 18-64 years (113 males and 162 females), and 66 senior citizens aged 65-79 years (29 males and 37 females) from both (sub)urban and rural areas. Detailed description of the study population is given in Table 1. ASNS and the present study were approved by the ethics commission of the City of Vienna (EK_10_037_0310). Additionally to the identification of BPA exposure in the present study population, phthalate metabolite exposures were also investigated. The results were reported elsewhere [13] .
Chemical analysis
Urinary total BPA concentrations (free and conjugated) were analysed by on-line solid-phase-extraction highperformance liquid chromatography tandem-mass spectrometry (on-line SPE-HPLC-MS/MS) after enzymatic hydrolysis with β-glucuronidase. The analytic method was adopted from Völkel et al. [14] . Detailed description of the analysis including validation data was published elsewhere [15] .
The HPLC systems used in the present study were an Agilent Technologies 1290 Infinity Series and an Agilent Technologies 1200 Infinity Series (Agilent Technologies, Santa Clara, CA, USA), and the MS detector system was an AB Applied Biosystem MDS SCIEX 4000 QTRAP LC/ MS/MS System (AB Sciex Technologies, Framingham, MA, USA) allowing detection through specific mass transitions in electrospray (ESI) negative mode, and quantification in multiple reaction monitoring (MRM) mode. The trap column used was an Oasis HLB 25 µm 2.1x20 mm (Waters Corporation, Massachusetts, USA) and the analytical column used was a Luna 5µ C18(2) 100A, 100x2.00 mm 5 micron (Phenomenex, California, USA). The quantitation limit (LOQ) was determined according to DIN 32645 [16] . The detection limit (LOD) was set as LOQ/2 and was 1.25 µg/l. Between-day imprecision and accuracy were reasonable, the relative standard deviation (RSD) was 14.4% and the mean relative recovery was 98.3%.
In cases of analysed urinary total BPA levels exhibiting concentrations of >10 µg/l, an additional analysis of free BPA concentrations was performed to exclude the possibility of potential contamination of the samples.
Creatinine concentrations of individual urine samples were measured via a clinical diagnosis system (Vitros, Ortho-Clinical Diagnostics, Germany) by the use of colorimetric assay. Data were provided by the Department of Nutritional Sciences.
Statistical analysis
Statistical analyses were conducted using IBM ® SPSS ® Statistics Version 21. Descriptive statistics including ranges, medians and 95 th percentiles were determined for urinary total BPA concentrations expressed in µg/l, and for creatinine-adjusted total BPA concentrations expressed in µg/g. For data treatment, total BPA concentrations below the LOQ were set to LOQ/2, and concentrations below the LOD were set to 0. For the investigations of statistically significant associations or differences, Mann-Whitney U tests and Kruskal-Wallis tests were performed dependent on the data type. Potential correlations were investigated by performing Spearman correlations because of not normally distributed data.
Daily intake estimates
The individual daily BPA intakes (DI) based on urinary total BPA concentrations were estimated according to two different calculation models. For the volume-based calculation model, estimation procedure published in Koch et al. [17] was used where UC is the analysed urinary total BPA concentration, UV 24h is the reference value for urinary volume excreted per day, F UE is the molar fraction value and bw is the bodyweight. For the creatinine-based calculation model, the formula published in Frederiksen et al. [18] was used where UE crea is the analysed urinary total BPA concentration per creatinine, CE smoothed is the reference value for the urinary creatinine excretion, F UE is the molar fraction value and bw is the bodyweight.
Reference values used for excreted urinary volume within 24 hours (UV 24h ) were provided from Geigy [19] for children and adolescents, and from Hays et al. [20] for adults and senior citizens, and reference values for 24-hour urinary creatinine excretion (CE smoothed ) were provided from Remer et al. [21] for children and adolescents, and from Koch et al. [22] for adults and senior citizens. A molar fraction value (F UE ) of 1 was used, which expresses the urinary excreted BPA within 24 hours after oral application [17] .
Daily BPA intakes were estimated based on analysed total BPA levels in urine and were compared with acceptable exposure levels that can be ingested daily over the entire lifetime without leading to a significant risk to human health: the Reference Dose 
Results and discussion
Urinary total BPA concentrations
The results of analysis of total BPA concentrations in a total of 594 spontaneous urine samples of children, adolescents, adults and senior citizens are listed in Table 2 . In children aged 6-10 years (n=119) urinary BPA concentrations ranged between n.d. and 15 µg/l (P95: 5.1 µg/l) for creatinine-unadjusted and between n.d. and 21 µg/g creatinine (7.0 µg/g) for creatinine-adjusted levels. Children and adolescents aged 11-15 years (n=134) exhibited lower exposure levels, ranging between n.d. and 8.4 µg/l (3.1 µg/l) for unadjusted and between n.d. and 9.7 µg/g (2.6 µg/g) for creatinine-adjusted total BPA concentrations. Unadjusted urinary BPA concentrations in adults aged 18-64 years (n=275) were detected in the range of n.d.-17 µg/l (1.7 µg/l) and for creatinine-adjusted BPA concentrations in the range of n.d.-12 µg/g (2.3 µg/g). In senior citizens aged 65-79 years total BPA was detected at concentrations between n.d.-6.5 µg/l (3.2 µg/l) creatinineadjusted total BPA between were n.d.-5.0 µg/g (2.6 µg/g).
Total BPA was detected in only a small number of investigated urine samples with detection rates ranging between 10.6% in senior citizens and 22.0% in children aged 6-10 years for creatinine-unadjusted total BPA concentrations. The number of positive samples decreased with increasing age, showing the highest detection rates in younger children, who are the most vulnerable study population group. Differences between age groups were statistically significant for both creatinine-unadjusted (p=0.006) and creatinineadjusted total BPA levels (p=0.008) performing KruskalWallis tests. Additionally, correlations between age and total BPA concentrations were significant at a 0.01 significance level at a Spearman rank coefficient of -0.167.
In general, children are exposed to BPA to a greater degree than adults (e.g. [24] [25] [26] ). This may be explained by children's higher food consumption per body weight compared to adolescents and adults. In addition, higher exposures may reflect other sources and pathways of exposure [26] . Also physiology, developmental stages and behaviour may be contributors to higher exposure levels among children [27] .
Regarding sex, no significant differences in urinary total BPA levels between males and females could be identified. Additionally, the investigation of potential differences in total BPA exposure among participants from rural and (sub)urban residential areas showed no significant results.
For comparison of results of the present study with other study populations, a literature review was performed. In Table 3 , urinary total BPA exposures of European children and adolescents are shown. Those of European adults are displayed in Table 4 . Results from selected investigations in children and adolescents from European countries (see Table 3 ) showed median total BPA concentrations ranging between <LOQ in male and female German infants aged 1-5 months in 2008 [28] [32] . The detection rates from the selected studies ranged between 42% [28] and 100% [30, [33] [34] [35] [36] .
Median total BPA concentrations of selected studies shown in Table 4 ranged between <LOQ in women of childbearing age from Luxembourg in 2011-2012 [30] and 3.5 µg/l in male and female adults aged 20-74 years from Italy in 1998-2000 [37] for creatinine-unadjusted BPA. The P95 levels ranged between 4.7 µg/l in pregnant women [18] . Detection rates from the selected studies ranged between 16% [41] and 100% [30, 36] . Compared with the findings from previous European studies on urinary BPA exposure, concentrations detected in the investigated Austrian population were considerably lower. As shown in Table 2 , median creatinine-adjusted and creatinine-unadjusted total BPA concentrations were n.d., and highest P95 levels were identified in male children aged 6-10 years, amounting to 7.3 µg/l and 8.1 µg/g for creatinine-unadjusted BPA and creatinineadjusted BPA, respectively. Additionally, detection rates were very low, with a minimum of 8.1% in female senior citizens aged 65-79 years and a maximum of 28.8% in female adolescents aged 11-15 years. Related to these low detection rates, which are comparable to previous findings in Austrian populations [41] , results indicate a generally low BPA exposure in Austria. However, it has to be noted that the LOQ of 1.25 µg/l was higher compared to most previous performed studies. Thus, detection rates have to be handled with special care. Nevertheless, ranges and P95 levels can be compared to other study results.
Daily intake estimates
Estimation of individual daily BPA intakes from all sources among the study population was conducted according to two calculation models derived from Koch et al. [17] for volume excretion and from Frederiksen et al. [18] for creatinine excretion. Table 2 illustrates estimated daily intakes (ranges, medians and 95 th percentiles) for the investigated study population related to sex, age and residential areas for both volume-based and creatininebased calculation models. Daily intakes of BPA were further compared with available acceptable levels of exposure (TDI and RfD) in order to identify potential exceedances.
Derived from volume-based calculation model, daily BPA intakes ranged between 0 and 0. Concerning age, daily BPA intakes (95 th percentiles) decreased with increasing age between children and adults, and increased partially again in senior citizens based on both calculation models. The maximum daily intake value was observed in an adult female participant for the volume-based model, amounting to 0.44 µg/ kg bw/d, and in a male adolescent participant for the creatinine-based model, amounting to 0.45 µg/kg bw/d. Differences between the four study population age groups investigated (6-10 years, 11-15 years, 18-64 years and 65-79 years) were statistically significant (p=0.0 in KruskalWallis test) for both volume-based and creatinine-based daily BPA intakes. The observed daily BPA intakes were a multitude lower than the TDI of 4 µg/kg bw/d [2] and the RfD of 50 µg/kg bw/d [23] . Compared with results from selected previous studies, 95 th percentiles of daily BPA intakes were lower than or of similar magnitude to those of other comparable population groups from Germany [17] , Denmark [25] , and the USA [42, 43] .
Conclusion
The present study provides initial total BPA exposure data derived from large human biomonitoring data of a subset of the Austrian population which includes children and adolescents aged 6-15 years and adults and senior citizens aged 18-81 years. As shown in previous investigations in Austria [44] , total BPA exposure was lower in Austria compared to results from other countries. Similar to other findings, children exhibited higher exposure levels than older participants, showing again the high vulnerability of this population group. Neither differences in residential areas nor sex differences could be identified for the investigated population group.
The estimation of daily BPA intakes based on total BPA concentrations determined in spontaneous urine samples showed no exceedances of the available acceptable exposure levels TDI of 4 µg/kg bw/d and RfD of 50 µg/kg bw/d. In accordance with urinary BPA levels, the calculated daily intakes were lower in the investigated Austrian population compared to those of other European countries. An explanation for those discrepancies might be differences in lifestyle and nutrition, as well as differing sampling periods.
Although the total BPA exposure was low in Austria, the fact that especially children are exposed to BPA at higher degrees and the consideration of additional exposure to various other chemicals acting as endocrine active substances or disrupters (e.g. pesticide residues, cosmetic ingredients) as well as its classification as toxic for reproduction category 1B [45, 46] warrants further research.
As published by the Dutch National Institute for Public Health and the Environment (RIVM), new studies in animals have shown impairment of the immune system of unborn and young children following low BPA exposure. RIVM recommends to revisit the currently existing European standards for safe exposure and to reduce BPA exposure. Additionally, special attention should be given to the protection of young children as well as pregnant and breastfeeding women [47] .
